Food and drug administration (FDA) center for biologics evaluation and research (cber) biologic effectiveness and safety (best) innovative methods (IM) program COR: brian hively
Active Awarded Last action
- Contract number
- 75F40124F80370
- Awardee
-
The Mitre Corporation UEI DMHDNDCPWUD1
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $11,688,771
Award facts
- Contract value 92% obligated
-
- $11,688,771.00 Current, with exercised options
- $12,680,718.00 Potential, with all options
- Completion date 69% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- West McLean, VA 22102, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $5,064,109 | |
| Exercise an Option | $2,913,402 | |
| Original award | $3,711,260 |
About this award
The Food and Drug Administration issued a $12.68 million delivery order to The Mitre Corporation on September 27, 2024, supporting the Center for Biologics Evaluation and Research (CBER) Biologic Effectiveness and Safety (BEST) Innovative Methods (IM) Program, with ultimate completion on September 29, 2027.
This is a cost-plus-fixed-fee delivery order under a parent FFRDC vehicle. Place of performance is West McLean, VA. The order funds systems engineering, technical analysis, and program management services for FDA's biologics safety and effectiveness evaluation initiatives, including eHealth data exchange capabilities and technology infrastructure components.
Healtheway, Inc., a non-profit operator of the nationwide eHealth Exchange network, serves as a subcontractor providing health data sharing network access and support. In FY2025, the order generated $3.5 million in invoiced labor with 6.2 FTEs, all self-performed by Mitre without reported subcontractor hours.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Healtheway, Inc. | $50,000 | |
| Healtheway, Inc. | $400,000 |
Quick answers
Who was awarded contract 75F40124F80370?
75F40124F80370 was awarded to The Mitre Corporation by Food and Drug Administration (Department of Health and Human Services) on September 27, 2024.
How much is contract 75F40124F80370 worth?
The government has obligated $11,688,771 on 75F40124F80370. Its potential value, with all options, is $12,680,718.
Is contract 75F40124F80370 an order under another contract?
Yes. 75F40124F80370 is a delivery order under 75FCMC23D0004, an indefinite delivery contract.
Was contract 75F40124F80370 competed?
The extent of competition for 75F40124F80370 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award